The effect of capsule composition on the biocompatibility of alginate-poly-1-lysine capsules

References

• Ballinger W. F., Lacy P. E. Transplantation of intact pancreatic islets in rats. Surgery 1972; 72: 175–186
   PubMed Web of Science ®Google Scholar
• Bendtzen K., Mandrup-Poulsen T., Nerup J., Nielsen J. H., Dinarello C. A., Svenson M. Cytoxicity of human p17 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
   PubMed Web of Science ®Google Scholar
• Braun K., Kuttler B., Jahr H., Hahn H. J. Prevention of complement-mediated cytotoxicity against rat islets by encapsulation in a cellulose sulphate membrane. Hormone and Metabolism Research 1987; 19: 345–347
   PubMed Web of Science ®Google Scholar
• Calafiore R., Koh N., Alejandro R., Civantos F., Shyr A., Tsang W. G. Xenotransplantation of microencapsulated canine islets in diabetic mice. Advanced models for the therapy of insulin-dependent diabetes (Serono Symposia Publications from Raven Press vol. 37), P. Brunetti, W. K. Wadhausl. Raven Press, New York 1987; 353–357
   Google Scholar
• Calafiore R., Calcinaro F., Pietropaolo M., Basta G., Falorni A., Tsang W. G., Brunetti P. Xenotransplantation of microencapsulated porcine islets into diabetic mice. Diabetes Research and Clinical Practice 1988; 5(Suppl. 1)S334
   Google Scholar
• Clayton H. A., London N. J.M., Colloby P. S., Bell P. R. F., James R. F. L. The effect of capsule composition on the in vitro insulin release characteristics of alginate-poly-1-lysine encapsulated islets. Diabetes Research 1990; 14: 127–132
   PubMedGoogle Scholar
• Cole D. R., Waterfall M., Baird J. D. Cytokine-mediated destruction of microencapsulated pancreatic islets in vitro: a mechanism for graft failure?. Diabetic Medicine 1989a; 6(Suppl. 1)A5
   Google Scholar
• Cole D. R., Waterfall M., McIntyre M. A., Baird J. D. Site modification of inflammatory response to alginate-polylysine microcapsules in BB/Edinburgh rats. Diabetic Medicine 1989b; 6(Suppl. 1)A41
   Google Scholar
• Davie J. M., Lacy P. E. Basic concepts in transplantation immunology. Advanced models for the therapy of insulin-dependent diabetes (Serono Symposia Publications from Raven Press vol. 37), P. Brunetti, W. K. Waldhausl. Raven Press, New York 1987; 279–283
   Google Scholar
• Fan M-Y., Lum Z-P., Fu X-W., Levesque L., Tai I. T., Sun A. M. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 1990; 39: 519–522
   PubMed Web of Science ®Google Scholar
• Festing M. F. W. Athymic nude rats. Immunological defects of laboratory animals, volume 1, M. E. Gershwin, B. Merchant. Plenum, New York 1981; 267–283
   Google Scholar
• Hegre O. D., Enriquez A. J., Ketchum R. J., Weinhaus A. J., Serie J. R. Islet transplantation in spontaneously diabetic BB/Wor rats. Diabetes 1989; 38: 1148–1154
   PubMed Web of Science ®Google Scholar
• Hiller W., Klempnauer J. Long-term metabolic advantages of renal subcapsular over intraportal transplantation of isolated islets of Langerhans. Diabetes 1989; 38(Suppl. 1)301
   Google Scholar
• Kubicka U., Olszewski W. L. Free peritoneal cells in the human peritoneal cavity. The peritoneum and peritoneal access, S. Bengmark. Butterworth and Co. (publishers) Ltd., London 1989; 53–59
   Google Scholar
• Lacy P. E., Finke E. H., Janney C. G., Davie J. M. Prolongation of islet xenograft survival by in vitro culture of rat megaislets in 95% oxygen. Transplantation 1982; 33: 588–592
   PubMedGoogle Scholar
• Leiter E. H. Murine macrophages and pancreatic beta cells. Chemotactic properties of insulin and beta-cytostatic action of interleukin-1. Journal of Experimental Medicine 1987; 166: 1174–1179
   PubMed Web of Science ®Google Scholar
• Lim F., Sun A. M. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908–910
   PubMed Web of Science ®Google Scholar
• London N. J. M., Chamberlain R. L., Rumford G. M., James R. F. L., Bell P. R. F. A simple sturdy micro-droplet generator for cell encapsulation. Surgical Research Communications 1989; 4: 271–274
   Google Scholar
• Lord G. H. Regulation and reasons for biocompatibility testing. Techniques of biocompatibility testing, D. F. Williams. CRC Press Inc., Boca Raton, Florida 1986; Volume 1: 5–33
   Google Scholar
• Mandrup-Poulsen T., Bendtzen K., Nerup J., Dinarello C. A., Svenson M., Nielsen J. H. Affinity-purified human interleukin-1 is cytotoxic to isolated islets of Langerhans. Diabetologia 1986; 29: 63–67
   PubMed Web of Science ®Google Scholar
• Marliss E. B., Nakhooda A. F., Poussier P., Sima A. A. F. The diabetic syndrome of the ‘BB’ Wistar rat: possible relevance to Type 1 (insulin-dependent) diabetes in man. Diabetologia 1982; 22: 225–232
   PubMed Web of Science ®Google Scholar
• McDowell R. H. Properties of Alginates, Fifth edition. Kelco International, London 1986, Revised
   Google Scholar
• Mellegren A., Schnell Landstrom A. H., Petersson B., Andersson A. The renal subcapsular site offers better growth conditions for transplanted mouse pancreatic islet cells than the liver or spleen. Diabetologia 1986; 29: 670–672
   PubMedGoogle Scholar
• Morson B. C. The peritoneum. Systemic pathology, Volume 3, Second edition, C. W. St Symmers. Churchill Livingstone, Edinburgh 1978; 1180–1197
   Google Scholar
• Nakhooda A. F., Like A. A., Chappel C. I., Murray F. T., Marliss E. B. The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes 1977; 26: 100–112
   PubMed Web of Science ®Google Scholar
• O'Shea G. M., Sun A. M. Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice. Diabetes 1986; 35: 943–946
   PubMed Web of Science ®Google Scholar
• O'Shea G. M., Goosen M. F. A., Sun A. M. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochimica et Biophysica Acta 1984; 804: 133–136
   PubMed Web of Science ®Google Scholar
• Pizzoferrato A., Vespucci A., Ciapetti G., Stea S. Chemotactic behaviour of macrophages under biomaterial influence. Techniques ofbiocompatibility testing, volume 2, D. F. Willliams. CRC Press Inc., Boca Raton, Florida 1986; 109–121
   Google Scholar
• Poussier P., Nakhooda A. F., Falk J. A., Lee C., Marliss E. B. Lymphopenia and abnormal lymphocyte subsets in the ‘BB’ rat: Relationship to the diabetic syndrome. Endocrinology 1982; 110: 1825–1827
   PubMedGoogle Scholar
• Prowse S. J., Bellgrau D., Lafferty K. J. Islet allografts are destroyed by disease occurrence in the spontaneously diabetic BB rat. Diabetes 1986; 35: 110–114
   PubMed Web of Science ®Google Scholar
• Puntis M. Peritoneal defence mechanisms. The peritoneum and peritoneal access, S. Bengmark. Butterworth and Co. (Publishers) Ltd., London 1989; 74–84
   Google Scholar
• Rabinovitch A., Pukel C., Baquerizo H. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures. Endocrinology 1988; 122: 2393–2398
   PubMed Web of Science ®Google Scholar
• Reach G. Artificial or bioartificial systems for the totally automatic treatment of diabetes mellitus: The gap between the dream and the reality. Diabetes Nutrition Metabolism 1989; 2: 165–170
   Google Scholar
• Reece-Smith H., Du Toit D. F., McShane P., Morris P. J. Prolonged survival of pancreatic islet allografts transplanted beneath the renal capsule. Transplantation 1981; 31: 305–306
   PubMedGoogle Scholar
• Ricker A., Stockberger S. Hyperimmune response to microencapsulated xenogenic tissue in NOD mice. Diabetes 1986; 35(Suppl. 1)61A
   PubMedGoogle Scholar
• Sandler S., Andersson A., Hellerstrom C. Inhibitory effects of interleukin-1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987; 121: 1424–1431
   PubMed Web of Science ®Google Scholar
• Sun A. M. Microencapsulation of pancreatic islet cells: a bioartificial endocrine pancreas. Methods in Enzymology 1988; 137: 575–580
   PubMed Web of Science ®Google Scholar
• Sun A. M., O'Shea G. M., Yuan Z. Y., Ma F., Cai Z. Alio- and xenotransplantation of microencapsulated islets of Langerhans. Advanced models for the therapy of insulin-dependent diabetes (Serono Symposia Publications from Raven Press vol. 37), P. Brunetti, W. K. Waldhausl. Raven Press, New York 1987; 303–307
   Google Scholar
• Sun A. M., Fan M., Lum Z., Fu X., Norton J. Bioartificial pancreas: reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Artificial Organs 1989; 13: 567
   Google Scholar
• Tze W. J., Tai J. Biocompatibility and immunological studies of microencapsulation with cross-linked alginate capsules. Transplantation 1982; 33: 563–564
   PubMedGoogle Scholar
• Weber C. J., Zabinski S., Koschitzky T., Wicker L., Rajotte R., D'Agati V., Peterson L., Norton J., Reemtsma K. The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in NOD mice. Transplantation 1990; 49: 396–404
   PubMed Web of Science ®Google Scholar
• Woehrle M., Markmann J. F., Silvers W. K., Barker C. F., Naji A. Transplantation of cultured pancreatic islets to BB rats. Surgery 1986; 100: 334–341
   PubMedGoogle Scholar
• Wu Z., Lu Z., Sun A. M. Preliminary report on microencapsulated islet transplantation in experimental diabetes mellitus in China. International Journal of Pancreatology 1988; 3: 91–100
   PubMedGoogle Scholar
• Zawalich W. S., Diaz V. A. Interleukin-1 inhibits insulin secretion from isolated perifused rat islets. Diabetes 1986; 35: 1119–1123
   PubMed Web of Science ®Google Scholar